Earnings History Data for Assertio Holdings, Inc. (ASRT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Assertio Holdings, Inc.

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-05-2025	AH		ASRT	Assertio Holdings, Inc.	61.24	-0.14	-0.05	0.03	Assertio Holdings GAAP EPS of -$0.14 misses by $0.08, revenue of $26.49M misses by $1.03M [5/12/2025 4:07 PM]	0.6087	-0.01 (-1.09%)	0.60	-0.02 (-2.49%)	0.51 - 1.80	595,536	340,000	3,657
Assertio Holdings GAAP EPS of -$0.14 misses by $0.08, revenue of $26.49M misses by $1.03M [5/12/2025 4:07 PM] Assertio outlines 2025 transformation phase with $108M-$123M revenue guidance while advancing Rolvedon and Sympazan growth [5/12/2025 8:18 PM] Assertio Holdings Inc (ASRT) Q1 2025 Earnings Report Preview: What to Expect [May-09-25 09:48AM] Assertio Reports First Quarter 2025 Financial Results [2025-05-12 04:01PM] Assertio: Q1 Earnings Snapshot [2025-05-12 04:20PM] Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates [2025-05-12 05:15PM]
12-03-2025	AH		ASRT	Assertio	73.00	-0.11	-0.04	0.00	Assertio Holdings Non-GAAP EPS of -$0.03 misses by $0.04, revenue of $32.1M beats by $3.43M [3/12/2025 4:15 PM]	0.7206	-0.06 (-7.45%)	0.78	0.0 (0.18%)	0.68 - 1.80	752,127	350,000	7,690
Assertio Holdings Non-GAAP EPS of -$0.03 misses by $0.04, revenue of $32.1M beats by $3.43M [3/12/2025 4:15 PM] Assertio Reports Fourth Quarter and Full Year 2024 Financial Results [2025-03-12 04:05PM] Assertio: Q4 Earnings Snapshot [2025-03-12 04:30PM] Assertio Holdings Inc (ASRT) Q4 2024 Earnings Call Highlights: Strategic Growth Amidst Challenges [2025-03-13 03:08AM] Q4 2024 Assertio Holdings Inc Earnings Call [2025-03-13 12:58PM]
11-11-2024	AH		ASRT	Assertio Holdings, Inc.	96.29	-0.03	-0.05	-0.01	Assertio Holdings Non-GAAP EPS of $0.03, revenue of $228.7M beats by $199.83M [11/11/2024 4:03 PM]	0.8471	-0.08 (-8.42%)	0.98	0.05 (5.56%)	0.73 - 1.80	1,563,910	970,000	127,702
Assertio Holdings Non-GAAP EPS of $0.03, revenue of $228.7M beats by $199.83M [11/11/2024 4:03 PM] Earnings Snapshot: Assertio Holdings tops Q3 expectations; Rolvedon sales remain stable [11/11/2024 4:14 PM] Assertio stock gains amid Q3 earnings, clash with activist investor [11/11/2024 5:49 PM] Buxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related Fraud [Nov-08-24 09:00AM] Assertio Holdings Inc (ASRT) Q3 2024: Everything You Need to Know Ahead of Earnings [Nov-08-24 07:06AM] Assertio Provides Response to Letter from Short-seller [2024-11-11 07:30AM] Buxton Helmsley Releases Evidence of Product-Related Fraud at Assertio [2024-11-11 03:41PM] Assertio Reports Third Quarter 2024 Financial Results [2024-11-11 04:02PM] Assertio: Q3 Earnings Snapshot [2024-11-11 04:09PM] Q3 2024 Assertio Holdings Inc Earnings Call [2024-11-12 09:41AM]
07-08-2024	AH		ASRT	Assertio Holdings, Inc.	122.71	-0.04	-0.02	0.13	Assertio Holdings Non-GAAP EPS of $0.02 in-line, revenue of $31.13M beats by $1.05M [8/7/2024 4:02 PM]	1.08	-0.15 (-12.20%)	1.23	0.0 (0.00%)	0.73 - 3.47	1,918,400	1,150,000	78,512
Assertio Holdings Non-GAAP EPS of $0.02 in-line, revenue of $31.13M beats by $1.05M [8/7/2024 4:02 PM]
06-05-2024	AH		ASRT	Assertio Holdings, Inc.	95.95	0.03	-0.01	-0.07	Assertio Holdings Non-GAAP EPS of $0.04 beats by $0.05, revenue of $31.9M beats by $2.39M [5/6/2024 4:03 PM]	1.10	-0.12 (-9.84%)	1.19	-0.03 (-2.48%)	0.73 - 8.01	1,230,837	1,200,000	45,596
Assertio Holdings Non-GAAP EPS of $0.04 beats by $0.05, revenue of $31.9M beats by $2.39M [5/6/2024 4:03 PM]
11-03-2024	AH		ASRT	Assertio Holdings, Inc.	86.31	0.08	0.00	1.34	Assertio Holdings Non-GAAP EPS of $0.11, revenue of $32.99M misses by $0.82M [3/11/2024 4:02 PM]	1.01	0.07 (7.72%)	0.99	0.05 (5.71%)	0.77 - 8.01	4,631,094	710,000	177,840
Assertio Holdings Non-GAAP EPS of $0.11, revenue of $32.99M misses by $0.82M [3/11/2024 4:02 PM] Assertio Holdings files for $150M mixed shelf [3/12/2024 10:04 AM]
08-11-2023	AH		ASRT	Assertio Holdings, Inc.	124.90	-0.01	0.13	0.08	Assertio Holdings Non-GAAP EPS of $0.01 misses by $0.09, revenue of $35.63M misses by $14.8M [11/8/2023 4:04 PM]	1.20	-0.93 (-43.66%)	1.18	-0.95 (-44.60%)	1.08 - 8.01	9,999,167	1,130,000	1,026,729
Assertio Holdings Non-GAAP EPS of $0.01 misses by $0.09, revenue of $35.63M misses by $14.8M [11/8/2023 4:04 PM]
03-08-2023	AH		ASRT	Assertio Holdings, Inc.	299.47	0.13	0.14	0.16	Assertio Holdings Non-GAAP EPS of $0.19 misses by $0.03, revenue of $40.99M beats by $1.16M [8/3/2023 4:38 PM]	2.90	-2.45 (-45.89%)	3.01	-2.34 (-43.74%)	2.07 - 8.01	15,851,674	2,680,000	2,747,585
Assertio Holdings Non-GAAP EPS of $0.19 misses by $0.03, revenue of $40.99M beats by $1.16M [8/3/2023 4:38 PM]
09-05-2023	PM	Before the open (May 9)	ASRT	Assertio Holdings, Inc.	342.34	-0.07	0.13	0.20	Assertio Therapeutics Non-GAAP EPS of $0.29 beats by $0.07, revenue of $42.47M beats by $4.83M [5/9/2023 7:19 AM]	7.00	0.74 (11.74%)	6.81	0.55 (8.79%)	1.86 - 7.33	6,517,514	3,050,000	439,646
Assertio Therapeutics Q1 2023 Earnings Preview [5/8/2023 12:31 PM] Assertio Therapeutics Non-GAAP EPS of $0.29 beats by $0.07, revenue of $42.47M beats by $4.83M [5/9/2023 7:19 AM] Spectrum Pharmaceuticals rises as co. says its Q1 net sales up 54% Q/Q [5/9/2023 9:12 AM]
08-03-2023	AH	4:00 PM ET (Mar 8)	ASRT	Assertio Holdings, Inc.	258.37	1.34	0.23	0.10	Assertio Therapeutics Non-GAAP EPS of $0.32 beats by $0.12, revenue of $50.35M beats by $2.91M [3/8/2023 4:04 PM]	6.66	0.70 (11.66%)	5.95	-0.01 (-0.17%)	1.86 - 7.00	5,427,740	3,160,000	16,770
Assertio Therapeutics Non-GAAP EPS of $0.32 beats by $0.12, revenue of $50.35M beats by $2.91M [3/8/2023 4:04 PM] Assertio quarterly results beat on both lines; 2023 sales guidance in line with consensus [3/8/2023 4:37 PM]
08-11-2022	AH	4:00 PM ET (Nov 8)	ASRT	Assertio Holdings, Inc.	127.67	0.08	0.07	0.08	Assertio Therapeutics Non-GAAP EPS of $0.22 beats by $0.11, revenue of $34.21M beats by $2.86M [11/8/2022 4:26 PM]	2.66	0.04 (1.53%)	2.80	0.18 (6.87%)	1.19 - 4.44	1,531,891	840,000	47,138
Assertio Therapeutics Non-GAAP EPS of $0.22 beats by $0.11, revenue of $34.21M beats by $2.86M [11/8/2022 4:26 PM] Assertio Reports Third Quarter 2022 Financial Results [Nov-08-22 04:01PM]
08-08-2022	PM	8:30 AM ET (Aug 8)	ASRT	Assertio Holdings, Inc.	141.30	0.16	0.08	-0.32		3.65	-0.34 (-8.65%)	4.40	0.41 (10.28%)	0.85 - 4.44	2,686,458	1,600,000	137,293
Assertio Therapeutics reports Q2 earnings; raises FY2022 financial guidance [8/8/2022 7:20 AM]
09-05-2022	AH	4:00 PM ET (May 9)	ASRT	Assertio Holdings, Inc.	95.20	0.20	0.09	0.12	Assertio Therapeutics Non-GAAP EPS of $0.38, revenue of $36.54M beats by $3.48M [5/9/2022 4:39 PM]	2.20	0.32 (17.02%)	2.12	0.24 (12.77%)	0.85 - 3.52	1,851,024	540,000	86,699
Assertio Therapeutics Non-GAAP EPS of $0.38, revenue of $36.54M beats by $3.48M [5/9/2022 4:39 PM] Assertio Reports First Quarter 2022 Financial Results [May-09-22 04:01PM] Assertio (ASRT) Surpasses Q1 Earnings and Revenue Estimates [May-09-22 05:15PM] Sidoti May Virtual Micro Cap Investor Conference [May-10-22 07:00AM]
09-03-2022	PM	6:00 AM ET (Mar 9)	ASRT	Assertio Holdings, Inc.	101.32	0.10	0.12	-0.80	Assertio Therapeutics GAAP EPS of $0.10 misses by $0.02, revenue of $33.33M beats by $2.56M [3/9/2022 8:56 AM]	2.58	0.41 (18.58%)	2.26	0.08 (3.67%)	0.85 - 4.12	863,517	440,000	25,996
Assertio Therapeutics Q4 Earnings Preview [3/8/2022 11:32 AM] Assertio Therapeutics GAAP EPS of $0.10 misses by $0.02, revenue of $33.33M beats by $2.56M [3/9/2022 8:56 AM] Assertio Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-09-22 08:30AM] Assertio (ASRT) Q4 Earnings Lag Estimates [Mar-09-22 09:45AM]
04-11-2021	AH	4:00 PM ET (Nov 4)	ASRT	Assertio Holdings, Inc.	50.72	0.08	-0.04	-0.36	Assertio Therapeutics EPS beats by $0.24, beats on revenue [11/4/2021 4:03 PM]	1.48	0.37 (32.88%)	1.27	0.16 (14.41%)	0.85 - 5.80	13,581,437	1,190,000	3,702,391
Assertio Therapeutics EPS beats by $0.24, beats on revenue [11/4/2021 4:03 PM] Assertio Reports Third Quarter 2021 Financial Results [Nov-04-21 04:01PM] Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates [Nov-04-21 05:45PM] Sidoti Microcap Virtual Conference [Nov-05-21 12:00PM]
05-08-2021	AH	4:00 PM ET (Aug 5)	ASRT	Assertio Holdings, Inc.	58.22	-0.32	-0.08	-1.40	Assertio Therapeutics EPS misses by $0.24, beats on revenue; raises full year guidance [8/5/2021 4:20 PM]	1.25	-0.08 (-6.01%)	1.35	0.02 (1.50%)	1.15 - 5.80	1,069,440	490,000	20,449
Assertio Reports Second Quarter 2021 Financial Results [Aug-05-21 04:01PM]
06-05-2021	AH	4:00 PM ET (May 6)	ASRT	Assertio Holdings, Inc.	91.39	0.03	-0.01	0.58	Assertio Therapeutics EPS beats by $0.04, beats on revenue [5/6/2021 4:31 PM]	0.57	0.07 (14.30%)	0.62	0.12 (24.32%)	0.33 - 1.45	21,032,676	4,530,000	11,001,241
Assertio Therapeutics EPS beats by $0.04, beats on revenue [5/6/2021 4:31 PM] Assertio shares rise on Q1 revenue strength, provides FY forecast [5/7/2021 11:28 AM] Assertio Holdings, Inc. Partners with Cove, a Leading Migraine Telemedicine Platform, To Launch Direct to Patient Digital Campaign to Increase Accessibility of CAMBIA® (diclofenac potassium) and SPRIX® (ketorolac tromethamine) [May-05-21 09:00AM] Assertio Reports First Quarter 2021 Financial Results [May-06-21 04:01PM]
11-03-2021	AH	4:00 PM ET (Mar 11)	ASRT	Assertio Holdings, Inc.	151.55	-0.20	-0.04	-2.65	Assertio Therapeutics EPS misses by $0.16, beats on revenue [3/11/2021 4:02 PM]	0.9799	0.03 (2.94%)	0.9150	-0.04 (-3.88%)	0.33 - 1.45	11,561,482	14,887,544	335,858
Assertio Therapeutics EPS misses by $0.16, beats on revenue [3/11/2021 4:02 PM] Assertio Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-11-21 04:01PM]
06-11-2020	PM	6:00 AM ET (Nov 6)	ASRT	Assertio Holdings, Inc.	69.75	-0.09	-0.05	0.05	Assertio Therapeutics EPS misses by $0.05, beats on revenue [11/6/2020 6:03 AM]	0.48	-0.19 (-28.36%)	0.66	-0.01 (-1.49%)	0.45 - 1.71	3,686,648	257,374	27,098

07-08-2020	PM	8:00 AM ET (Aug 7)	ASRT	Assertio Holdings, Inc.	95.00	-0.35	-0.12	-0.21	Assertio Therapeutics EPS misses by $0.23, misses on revenue [8/7/2020 6:05 AM]	0.79	-0.14 (-15.51%)	0.8577	-0.08 (-8.27%)	0.55 - 2.92	3,138,530	623,835	127,120